Where I see patients (1)
My reviews
Selected research
- 
							A targeted gene expression biomarker predicts clinic low-risk meningioma recurrence.
							Neuro-oncology
 - 
							RNA splicing as a biomarker and phenotypic driver of meningioma DNA-methylation groups.
							Neuro-oncology
 - 
							Perivascular NOTCH3+ Stem Cells Drive Meningioma Tumorigenesis and Resistance to Radiotherapy.
							Cancer discovery
 
					
				
														
														
														
														
														
				
					
				
4.9